TF name | S.oneidensis MR-1 | S. putrefaciens CN-32 | S.putrefaciens W3-18-1 | Shewanella sp. ANA-3 | Shewanella sp. MR-4 | Shewanella sp. MR-7 | S. baltica OS155 | S. denitrificans OS217 | S. frigidimarina NCIMB 400 | S.amazonensis SB2B | S. loihica PV-4 | S. pealeana ATCC 700345 | S.halifaxensis HAW-EB4 | S. piezotolerans WP3 | S. sediminis HAW-EB3 | S.woodyi ATCCC 51908 | Regulon functional role |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
A. Regulons inferred from the analysis of metabolic pathways | |||||||||||||||||
AlgR* | - | - | - | - | - | - | - | - | + | - | - | - | - | - | - | - | Hexuronate utilization |
AraR* | - | + | + | + | + | + | - | - | - | - | - | - | - | - | - | - | Arabinose utilization |
BglR* | - | - | - | - | - | - | + | + | + | + | - | - | - | + | - | + | Beta-glucoside utilization |
HmgR* | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | Tyrosine degradation |
HypR* | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | Hydroxyproline utilization |
LiuR | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | Amino acid utilization |
LldR* | + | + | + | + | + | + | + | - | + | + | + | + | + | + | + | - | Lactate utilization |
MalR* | + | - | - | + | + | + | + | + | + | + | + | - | - | + | - | + | Maltodextrin utilization |
ManR1* | - | - | - | - | - | + | - | - | - | + | - | - | - | - | - | - | Mannose utilization |
ManR2* | - | - | - | - | - | - | - | - | - | + | - | - | - | - | - | - | Mannose utilization |
MtlR2 | - | - | - | - | - | - | - | - | + | - | - | - | - | - | - | - | Mannitol utilization |
NagR | + | + | + | + | + | + | + | + | - | + | + | + | + | + | + | + | GlcNAc utilization |
PflR* | - | + | + | - | - | - | - | - | + | + | + | + | + | + | + | + | Formate metabolism |
PrpR* | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | Propionate utilization |
PUR* | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | Purine biosynthesis |
ScrR* | - | - | - | + | + | + | + | - | + | - | - | - | - | - | - | - | Sucrose utilization |
TreR* | - | - | - | - | - | - | - | - | + | - | - | - | - | - | - | + | Trehalose utilization |
XltR* | - | - | - | - | - | - | - | - | - | - | - | + | + | - | - | - | Xylitol utilization |
B. Regulons inferred from the analysis of chromosomal gene clusters | |||||||||||||||||
AzrR* | + | + | + | + | + | + | + | - | - | + | + | + | + | + | + | + | Superoxide stress |
CalR* | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | Aromatics utilization |
CueR2 | - | + | - | - | - | - | - | - | + | - | + | - | - | - | - | - | Copper efflux |
DeoR* | + | + | + | + | - | - | - | - | - | - | - | + | + | + | + | + | Nucleoside utilization |
PnuR* | + | + | + | - | - | - | + | - | - | - | - | - | - | - | - | - | NAD metabolism |
SO0072 | + | + | + | + | + | + | + | + | + | + | + | + | - | + | - | + | ABC efflux transporter |
SO0082 | + | - | - | - | + | - | + | - | + | - | - | - | - | - | - | - | Benzoate degradation |
SO0193 | + | + | + | + | + | + | + | - | + | + | + | - | - | - | - | - | Phospholipid synthesis |
SO0734 | + | + | + | - | - | - | + | - | - | - | - | - | - | - | - | - | hypothetical transporter |
SO1393 | + | - | - | + | + | + | - | - | - | - | + | - | - | - | - | - | hypothetical |
SO1415 | + | - | - | - | + | - | - | - | - | - | + | + | + | - | + | - | flavocytochrome c |
SO1578 | + | - | - | + | + | + | + | - | - | + | + | - | - | - | - | + | Glutathione detoxification |
SO1703 | + | + | + | + | + | + | + | + | - | + | + | + | + | + | + | - | multidrug efflux |
SO1758 | + | + | + | + | + | + | + | - | - | + | + | - | - | - | + | + | hypothetical |
SO2282 | + | + | + | + | + | + | + | - | - | + | - | + | + | + | - | + | Amino acid efflux |
SO3277 | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | multidrug efflux |
SO3385 | + | + | + | + | + | + | + | - | - | - | - | - | - | - | - | - | hypothetical |
SO3393 | + | + | + | + | + | + | + | + | + | + | + | - | - | + | + | + | xenobiotic reductase |
SO3494 | + | + | + | + | + | + | + | + | + | - | - | - | - | - | - | - | multidrug efflux |
SO3627 | + | - | - | - | - | - | - | - | - | - | - | - | - | - | + | - | flavocytochrome c |
SO4326 | + | - | - | + | - | - | - | - | - | + | - | + | + | + | + | + | multidrug efflux |
SO4468 | + | + | + | + | + | + | + | + | - | + | - | - | - | + | + | - | hypothetical |
SO4705 | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | hypothetical |